Deferred Tax Assets, Valuation Allowance of Keenova Therapeutics plc from 28 Sep 2012 to 31 Jul 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Keenova Therapeutics plc quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 28 Sep 2012 to 31 Jul 2025.
  • Keenova Therapeutics plc Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Jul 2025 was $73,000,000.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Keenova Therapeutics plc Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $73,000,000 31 Jul 2025 10-Q 10 Nov 2025 2025 Q3
Q4 2024 $3,757,300,000 -$826,500,000 -18% 27 Dec 2024 10-K 13 Mar 2025 2024 FY
Q4 2023 $4,583,800,000 -$409,100,000 -8.2% 29 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 $4,584,800,000 14 Nov 2023 10-K 13 Mar 2025 2024 FY
Q4 2022 $4,992,900,000 -$1,351,300,000 -21% 30 Dec 2022 10-K 13 Mar 2025 2024 FY
Q2 2022 $5,129,700,000 16 Jun 2022 10-K 13 Mar 2025 2024 FY
Q4 2021 $6,344,200,000 +$233,400,000 +3.8% 31 Dec 2021 10-K 13 Mar 2025 2024 FY
Q4 2020 $6,110,800,000 +$2,979,300,000 +95% 25 Dec 2020 10-K 15 Mar 2022 2021 FY
Q4 2019 $3,131,500,000 +$526,600,000 +20% 27 Dec 2019 10-K 10 Mar 2021 2020 FY
Q4 2018 $2,604,900,000 +$337,000,000 +15% 28 Dec 2018 10-K 26 Feb 2020 2019 FY
Q4 2017 $2,267,900,000 +$869,600,000 +62% 29 Dec 2017 10-K 26 Feb 2019 2018 FY
Q4 2016 $1,398,300,000 +$1,368,800,000 +4640% 30 Dec 2016 10-K 27 Feb 2018 2017 FY
Q3 2016 $564,900,000 +$331,900,000 +142% 30 Sep 2016 10-QT 07 Feb 2017 2016 Q4
Q2 2016 $29,500,000 +$21,300,000 +260% 24 Jun 2016 10-Q 02 Aug 2016 2016 Q3
Q1 2016 $29,500,000 +$21,300,000 +260% 25 Mar 2016 10-Q 03 May 2016 2016 Q2
Q4 2015 $29,500,000 25 Dec 2015 10-Q 02 Feb 2016 2016 Q1
Q3 2015 $233,000,000 +$156,100,000 +203% 25 Sep 2015 10-K 29 Nov 2016 2016 FY
Q2 2015 $8,200,000 26 Jun 2015 10-Q 04 Aug 2015 2015 Q3
Q1 2015 $8,200,000 27 Mar 2015 10-Q 05 May 2015 2015 Q2
Q3 2014 $76,900,000 +$46,900,000 +156% 26 Sep 2014 10-K 24 Nov 2015 2015 FY
Q3 2013 $30,000,000 +$14,700,000 +96% 27 Sep 2013 8-K 03 Apr 2015 2014 FY
Q3 2012 $15,300,000 28 Sep 2012 10-K 13 Dec 2013 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.